INARI MEDICAL, INC.

(NARI)
  Report
Delayed Nasdaq  -  05/19 04:00:00 pm EDT
59.62 USD   -0.78%
05/18INSIDER SELL : Inari Medical
MT
05/13Inari Medical Announces Launch of 2021 Ethos and Sustainability Report
AQ
05/12TRANSCRIPT : Inari Medical, Inc. Presents at Bank of America 2022 Healthcare Conference, May-12-2022 10:40 AM
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Inari Medical to Seek Acquisitions

01/12/2022 | 03:00pm EDT

Inari Medical, Inc. (NasdaqGS:NARI) will look for acquisitions. Bill Hoffman, Chief Executive Officer said "And we're sitting now, of course, on a public company valuation, a significant balance sheet and I think the potential for us to pursue adjacent markets strategic acquisitions, that's a real possibility. We have a strategy and BD team. We'll have very little to say about that for obvious reasons going forward".


© S&P Capital IQ 2022
Stocks mentioned in the article
ChangeLast1st jan.
INARI MEDICAL, INC. -0.78% 59.62 Delayed Quote.-34.68%
ON SEMICONDUCTOR CORPORATION 0.43% 56.07 Delayed Quote.-17.45%
All news about INARI MEDICAL, INC.
05/18INSIDER SELL : Inari Medical
MT
05/13Inari Medical Announces Launch of 2021 Ethos and Sustainability Report
AQ
05/12TRANSCRIPT : Inari Medical, Inc. Presents at Bank of America 2022 Healthcare Conference, M..
CI
05/04INARI MEDICAL, INC. Management's Discussion and Analysis of Financial Condition and Re..
AQ
05/04TRANSCRIPT : Inari Medical, Inc., Q1 2022 Earnings Call, May 04, 2022
CI
05/04Earnings Flash (NARI) INARI MEDICAL Posts Q1 Revenue $86.8M, vs. Street Est of $83.6M
MT
05/04Inari Medical Reports First Quarter 2022 Financial Results
AQ
05/04Inari Medical, Inc. Revises Revenue Guidance for the Full Year 2022
CI
05/04Inari Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/03INARI MEDICAL, INC.(NASDAQGS : NARI) added to S&P 400
CI
More news
Analyst Recommendations on INARI MEDICAL, INC.
More recommendations
Financials (USD)
Sales 2022 365 M - -
Net income 2022 -39,1 M - -
Net cash 2022 316 M - -
P/E ratio 2022 -78,4x
Yield 2022 -
Capitalization 3 167 M 3 167 M -
EV / Sales 2022 7,80x
EV / Sales 2023 6,53x
Nbr of Employees 800
Free-Float 85,0%
Chart INARI MEDICAL, INC.
Duration : Period :
Inari Medical, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INARI MEDICAL, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 59,62 $
Average target price 111,67 $
Spread / Average Target 87,3%
EPS Revisions
Managers and Directors
William H. Hoffman President, Chief Executive Officer & Director
Mitchell C. Hill Chief Financial Officer
Don B. Milder Chairman
Thomas Tu Chief Medical Officer
Tara Dunn VP-Clinical Affairs & Market Development
Sector and Competitors
1st jan.Capi. (M$)
INARI MEDICAL, INC.-34.68%3 167
GETINGE AB-27.08%7 842
MASIMO CORPORATION-53.26%7 596
NOVOCURE LIMITED-1.37%7 293
SHOCKWAVE MEDICAL, INC.-10.16%5 810
PENUMBRA, INC.-50.46%5 445